David Gilham, Celyad

"There are always more options than you think. It's very easy to be stuck in a position and assume that there are very few doors open to you....no matter where you are in your career, it's important to realise that you always have options." David Gilham is a true pioneer of the CAR-T cell therapy field. Now the Chief Scientific Officer of Celyad, David has seen T-cell based technology grow from academic special interest to global concern producing treatments for patients every day. Along with sharing his career journey, David talked to us about: 🧪 The early days of CAR-T research 🧪 The pros and cons of working in a completely novel field 🧪 What a CSO does in a clinical-stage Biotech Enjoy!